AmeriPath
AmeriPath is a leading national provider of anatomic pathology, dermatopathology and molecular diagnostic services across the U.S.
Last updated September 1, 2026
Overview
AmeriPath is a leading national provider of anatomic pathology, dermatopathology and molecular diagnostic services to physicians, hospitals, clinical laboratories and surgery centers across the U.S. The company has a team of over 450 board-certified pathologists and Ph.D. level scientists, and operates outpatient laboratories as well as services in hospitals and ambulatory surgical centers. AmeriPath is a subsidiary of Quest Diagnostics.
History
AmeriPath is a leading national provider of anatomic pathology, dermatopathology and molecular diagnostic services to physicians, hospitals, clinical laboratories and surgery centers across the U.S. The company has a team of over 450 board-certified pathologists and Ph.D. level scientists. AmeriPath is a subsidiary of Quest Diagnostics.
Products and positioning
Haystack MRD™
Purpose-built, high-precision MRD testing to uncover residual disease with exceptional MRD detection sensitivity.
Flagship businesses
- Haystack MRD™
- Comprehensive test menu
- Immunohistochemistry (IHC)
- Histology
- Cytology and FNA
- Special stains
- Tissue consultation
- Flow cytometry
- Cytogenetics
- Molecular testing
Sources
Cite this profile: Cite the canonical profile. /brand-wiki/ameripath · Editorial policy · How profiles are compiled